Supreme Court temporarily greenlights firing of Biden-appointed FTC commissioner

The Supreme Court's decision to allow President Trump to fire a Federal Trade Commission (FTC) member without cause signals a potential re-evaluation of the 90-year-old Humphrey's Executor precedent, which limits presidential power over independent agencies. This move, part of a broader push to assert executive control, could significantly alter the regulatory landscape and the FTC's enforcement capabilities, potentially impacting how the agency pursues injunctions and penalties under statutes like the Sherman Act.

Analysis

The Supreme Court's temporary order allowing the termination of FTC Commissioner Rebecca Slaughter represents a significant step towards a potential re-evaluation of the 90-year-old precedent set by *Humphrey's Executor v. United States*. This precedent has historically insulated members of independent agencies like the Federal Trade Commission (FTC) from at-will presidential firings, ensuring regulatory continuity. The core of the current legal challenge, as argued by the Solicitor General, is that the FTC's executive power has expanded substantially since the 1930s, now including robust enforcement of statutes like the Sherman Act and the authority to seek injunctions and penalties. An eventual ruling that overturns or narrows *Humphrey's Executor* would fundamentally alter the structure of U.S. regulatory bodies, increasing the executive branch's control. This could lead to a more politicized FTC, where enforcement priorities in critical areas such as antitrust, M&A review, and consumer protection could shift abruptly with changes in administration, creating a less predictable regulatory environment for businesses.

Key Decisions for Investors

• Investors should closely monitor the Supreme Court's final ruling, as a decision weakening the independence of the FTC would introduce significant regulatory uncertainty and increase political risk for highly regulated sectors.
• Consider reviewing exposure to industries heavily reliant on M&A activity, such as technology and healthcare, as a more politically influenced FTC could alter the calculus for deal approvals, potentially increasing transaction risk.
• It is prudent to assess the long-term regulatory risk profile of portfolio companies, particularly those with dominant market positions that are frequent targets of antitrust scrutiny, as enforcement could become more volatile.